Investigating oral microbiome dynamics in chronic kidney disease and post-transplantation in continuous culture

被引:0
|
作者
Campbell, Paul M. [1 ]
Willmott, Thomas [1 ]
Summers, Angela [2 ]
Knight, Christopher G. [3 ]
Humphreys, Gavin J. [1 ]
Konkel, Joanne E. [4 ]
Augustine, Titus [2 ]
Mcbain, Andrew J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Manchester, England
[2] Manchester Acad Hlth Sci Ctr, Manchester Univ Hosp NHS Fdn Trust, Dept Renal & Pancreat Transplantat, Manchester, England
[3] Univ Manchester, Fac Sci & Engn, Sch Nat Sci, Manchester, England
[4] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, England
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
英国医学研究理事会;
关键词
urea; oral microbiome; kidney transplantation; chronic kidney disease; ANTIMICROBIAL SUSCEPTIBILITY; DENTAL BIOFILMS; PH; BACTERIA; STREPTOCOCCI; ENZYMES; HEALTH;
D O I
10.1128/spectrum.00598-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The oral microbiome is influenced by environmental factors in chronic kidney disease and following kidney transplantation affecting microbial composition, which may have implications for health and recovery. A major driver of oral microbiome perturbation is the accumulation of urea in saliva. We have modelled increased salivary urea concentrations associated with CKD and subsequent reductions that may occur post-transplantation. Oral microbiota were established in constant-depth film fermenters by inoculation with saliva. Duplicate validation runs were maintained with artificial saliva with baseline urea concentrations (0.205 mg/mL) for 21 days. Triplicate treatment runs were then done with baseline urea for 10 days (healthy phase) before urea was increased for 10 days to reflect CKD concentrations (0.92 mg/mL) (CKD phase). This was followed by reversion to baseline urea concentrations (post-transplant phase). Biofilms in primary validation runs reached dynamic stability within 5 days according to viable counting. DNA sequence data indicated minimal taxonomic variation over time and between low and high urea treatments despite background noise indicating changes in bacteria belonging to the family Gemellaceae and the genera TG5 and Leptotrichia. Significant differences in alpha and beta diversity occurred between low and high urea states but not following reversion to a low urea environment. Increased abundance of the TG5 was detected in late model phases, despite apparent count stability, and independent of changes in urea concentrations.IMPORTANCEThis study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery. This study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Effectiveness of Metformin in Kidney Transplant Recipients With Post-Transplantation Diabetes Mellitus
    Lee, Dongyeon
    Jung, Jiyun
    Lee, Jangwook
    Shin, Sung Joon
    Kim, Sichan
    Baek, Chung Hee
    Park, Su-Kil
    Park, Jae Yoon
    Kim, Hyosang
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 547 - 547
  • [42] Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention
    Conte, Caterina
    Secchi, Antonio
    ACTA DIABETOLOGICA, 2018, 55 (08) : 763 - 779
  • [43] Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention
    Caterina Conte
    Antonio Secchi
    Acta Diabetologica, 2018, 55 : 763 - 779
  • [44] Post-transplantation lymphoproliferative disease in pediatric kidney transplant recipientsearly success does not mean the battle is over!
    Cleper, Roxana
    TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 361 - 363
  • [45] Early kidney dysfunction post liver transplantation predicts late chronic kidney disease
    Velidedeoglu, E
    Bloom, RD
    Crawford, MD
    Desai, NM
    Campos, L
    Abt, PL
    Markmann, JW
    Mange, KC
    Olthoff, KM
    Shaked, A
    Markmann, JF
    TRANSPLANTATION, 2004, 77 (04) : 553 - 556
  • [46] Chronic kidney disease (CKD) complications in children post renal transplantation
    Feber, J.
    Geier, P.
    Chaudry, B.
    Wong, H.
    Filler, G.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1583 - 1583
  • [47] Treatment of post-transplantation bone disease: Clinical and economic aspects
    Fahrleitner-Pammer, A.
    Dobnig, H.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S3 - S3
  • [48] Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan
    Hsu, Chien-Ting
    Chang, Mei-Hwei
    Ho, Ming-Chih
    Chang, Hsiu-Hao
    Lu, Meng-Yao
    Jou, Shiann-Tarng
    Ni, Yen-Hsuan
    Chen, Huey-Ling
    Hsu, Hong-Yuan
    Wu, Jia-Feng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (11) : 1537 - 1545
  • [50] Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease
    Lane, E. L.
    Soulet, D.
    Vercammen, L.
    Cenci, M. A.
    Brundin, P.
    NEUROBIOLOGY OF DISEASE, 2008, 32 (02) : 220 - 228